Hong Jae Chon

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade

Hannah Yang, Won Suk Lee, So Jung Kong et al. · Journal of Clinical Investigation · 2019 · 291 citations · Full text

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma

Chang Gon Kim, Chan Kim, Sang Eun Yoon et al. · Journal of Hepatology · 2020 · 187 citations · Full text

Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma

Hong Jae Chon, Woo Jin Hyung, Chan Kim et al. · Annals of Surgery · 2016 · 157 citations · Full text